Sumitomo Pharma Co., Ltd. (FRA:DPM)
Germany flag Germany · Delayed Price · Currency is EUR
13.40
0.00 (0.00%)
At close: Dec 5, 2025

Sumitomo Pharma Ratios and Metrics

Millions EUR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Market Capitalization
5,3641,7899692,2283,5585,898
Upgrade
Market Cap Growth
266.79%84.67%-56.51%-37.37%-39.67%25.11%
Upgrade
Enterprise Value
6,6053,5753,2702,3974,4977,137
Upgrade
Last Close Price
13.404.522.385.458.5513.91
Upgrade
PE Ratio
6.0212.26--8.5113.62
Upgrade
PS Ratio
2.090.730.500.580.861.48
Upgrade
PB Ratio
3.511.711.010.790.711.18
Upgrade
P/TBV Ratio
----34.1537.03
Upgrade
P/FCF Ratio
40.4636.19-92.7420.095.91
Upgrade
P/OCF Ratio
31.0717.55-26.9615.365.65
Upgrade
EV/Sales Ratio
2.681.451.700.621.081.80
Upgrade
EV/EBITDA Ratio
8.6015.00--6.1712.04
Upgrade
EV/EBIT Ratio
10.2544.43--10.1217.06
Upgrade
EV/FCF Ratio
49.8272.31-99.7525.397.15
Upgrade
Debt / Equity Ratio
0.991.852.740.850.420.45
Upgrade
Debt / EBITDA Ratio
1.898.14--2.893.78
Upgrade
Debt / FCF Ratio
11.4239.27-99.8211.912.24
Upgrade
Asset Turnover
0.560.480.310.460.430.40
Upgrade
Inventory Turnover
1.811.461.211.851.641.61
Upgrade
Quick Ratio
0.830.430.250.651.271.19
Upgrade
Current Ratio
1.361.070.521.031.791.65
Upgrade
Return on Equity (ROE)
81.47%14.52%-111.89%-17.90%6.14%5.75%
Upgrade
Return on Assets (ROA)
9.25%0.99%-21.74%-6.46%2.86%2.65%
Upgrade
Return on Capital (ROIC)
14.15%1.52%-33.20%-9.23%3.95%3.60%
Upgrade
Return on Capital Employed (ROCE)
20.20%2.60%-90.60%-16.50%5.80%5.30%
Upgrade
Earnings Yield
16.61%8.16%-199.19%-23.15%11.75%7.34%
Upgrade
FCF Yield
2.47%2.76%-159.79%1.08%4.98%16.92%
Upgrade
Dividend Yield
---2.67%2.43%1.55%
Upgrade
Payout Ratio
0.00%0.01%--19.72%19.78%
Upgrade
Total Shareholder Return
---2.67%2.43%1.55%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.